Rosiglitazone hydrochloride
Rosiglitazone hydrochloride is a PPARγ agonist that enhances insulin sensitivity, primarily used in diabetes research. It is widely applied in both in vitro receptor binding assays and in vivo models of insulin resistance and glucose metabolism studies.
Product Specifications
CAS Number
302543-62-0
Product Name Alternative
Carcinoma, cancer, bladder, Autophagy, antihyperglycemic, Apoptosis, diabetes, diabetic, BRL 49653, BRL49653, BRL-49653, BRL-49653 HCl, Inhibitor, inhibit, neuroprotection, ovarian cancer, hepatocellular, HCC, mellitus, Ferroptosis, senescence, Peroxisome proliferator-activated receptors, PPAR, PPARγ, TRPV Channel, TRPChannel, TRPVChannel, TRP Channel, Transient receptor potential channels, Rosiglitazone, Rosiglitazone HCl, Rosiglitazone hydrochloride, Rosiglitazone Hydrochloride, smoke
Field of Research
Cell Biology, Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery
Purity
99.63% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:250 mg/mL (634.69 mM) ; Ethanol:73 mg/mL (185.33 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:10 mg/mL (25.39 mM)
Smiles
Cl.CN (CCOc1ccc (CC2SC (=O) NC2=O) cc1) c1ccccn1
Molecular Formula
C18H19N3O3S·HCl
Molecular Weight
393.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Purified Anti-Human CD11c Antibody[3.9]](https://cdn.genprice.uk/products/763/68dd14c4061270361e7d70eb/imageurl/e-ab-f1486a.webp)
